Form 4: Madrigal Pharmaceuticals Director Receives Stock Grant
Insider Transaction (Form 4)
John C Reed, a Director of Madrigal Pharmaceuticals, Inc., reported multiple transactions in common stock on August 15, 2026.
Summary
- Grant/award: acquired 647 Common Stock on August 15, 2026; holds 647 after (Direct).
- Grant/award: acquired 1,078 Stock Option (Right to Buy) on August 15, 2026; holds 1,078 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
John C Reed — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-15 | Grant/award | Common Stock | 647 | — | — | 647 |
| 2026-08-15 | Grant/award | Stock Option (Right to Buy) | 1,078 | — | — | 1,078 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-15 | Grant/award (647 shares) |
| 2026-08-15 | Grant/award (1,078 shares) |
Keywords
insider transaction, Form 4, MDGL, MADRIGAL PHARMACEUTICALS, INC., neutral, John C Reed
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.